IP Library › Granted Patent US 12,213,873
Granted Patent B2
US 12,213,873 · App. 18/103,852 · Granted Feb 4, 2025

Void occlusion device

Inventors: Andrew Weems (Athens, OH); Elizabeth Lawson (Johnson City, TN)
Assignee: Resilient Medical Corp.
A61F2/12A61F2210/0004A61F2230/0091A61F2250/0058
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,213,873
App. No.
18/103,852
Granted
Feb 4, 2025
Kind
B2
Abstract

A void occlusion device that includes a scaffold defining a plurality of voids and a reinforcement member is described. The scaffold is configured to permit the infiltration of human tissue into the plurality of voids. The reinforcement member extends through at least a portion of the scaffold and is configured to resist compressive forces exerted on the scaffold. Also described are embodiments where the void occlusion device is biocompatible, bioresorbable, elastic, and suitable for radio imaging.

Claims (19)

1. A void occlusion device comprising:

a scaffold comprising a three-dimensional latticed structure that defines a plurality of voids, wherein the scaffold is configured to permit penetration of human tissue into at least some of the plurality of voids, wherein the scaffold comprises a bioresorbable material composition; and

a reinforcement portion of said structure is configured to resist compressive forces if encountered by said scaffold.

2. The void occlusion device of claim 1 wherein the scaffold comprises a material composition that is biocompatible.

3. The void occlusion device of claim 1 wherein the scaffold comprises a strain to failure of at least 20%.

4. The void occlusion device of claim 1 wherein said device is adapted to be visible by x-ray when implanted.

5. The void occlusion device of claim 1 wherein the scaffold comprises aliphatic polycarbonate oligomers.

6. The void occlusion device of claim 1 wherein the scaffold is fabricated from a 3D printable polycarbonate.

7. The void occlusion device of claim 1 , wherein the reinforcement portion includes a spiral shaped member.

8. The void occlusion device of claim 7 , wherein the latticed structure further comprises a plurality of cells each having a hollow center portion formed by a weave formation of branching arms.

9. The void occlusion device of claim 8 wherein the center portions and the branching arms are curved such that channels are defined through the latticed structure from at least one cartesian direction.

10. The void occlusion device of claim 8 wherein the cell center portions and the branching arms are curved such that channels are formed through the latticed structure from one direction.

11. The void occlusion device of claim 8 further comprising a plurality of pores formed by said branching arms.

12. The void occlusion device of claim 1 , wherein the device is comprised of a shape memory material.

13. A void occlusion device comprising:

a generally disc shaped, three-dimensional scaffold structure adapted to be implanted in a breast, said scaffold having a plurality of voids, and wherein said voids are adapted to accommodate penetration of human tissue into at least some of the plurality of voids, the scaffold comprising:

a plurality of layers arranged in a stacked configuration, each layer comprising a plurality of concentric rings;

a plurality of members in each layer, extending outward from about a center point of said concentric rings, joining said rings in each of said layers; and,

a plurality of connectors which space said layers of rings apart, providing said three dimensional structure, wherein said connectors connect each of said layers to each adjacent layer in the structure, such that the scaffold structure is resistive to compressive forces.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 18, 2023
From: WEEMS, ANDREW; LAWSON, ELIZABETH
To: RESILIENT MEDICAL CORP.
Reel/Frame 063364/0888 →
Continuity (2)
Continuation 17078940 · Oct 23, 2020
Related Publication 20230172703A1 · Jun 8, 2023
References Cited (38)
US 5876446A · Agrawal · 1999 [cited by examiner]
US 8480735B2 · Rigotti et al. · 2013 [cited by applicant]
US 9399122B2 · Mosharrafa · 2016 [cited by examiner]
US 10524946B2 · Chen · 2020 [cited by examiner]
US 10898313B2 · Feinberg · 2021 [cited by examiner]
US 20040267362A1 · Hwang · 2004 [cited by examiner]
US 20050015154A1 · Lindsey · 2005 [cited by examiner]
US 20050102036A1 · Bartee · 2005 [cited by examiner]
US 20050288706A1 · Widomski · 2005 [cited by examiner]
US 20070061015A1 · Jensen · 2007 [cited by examiner]
US 20080241212A1 · Moses et al. · 2008 [cited by applicant]
US 20100310623A1 · Laurencin · 2010 [cited by examiner]
US 20120239161A1 · Datta · 2012 [cited by examiner]
US 20120253472A1 · Priewe · 2012 [cited by examiner]
US 20150057762A1 · Harms · 2015 [cited by examiner]
US 20160082235A1 · Mosharrafa · 2016 [cited by examiner]
US 20170095337A1 · Pasini · 2017 [cited by examiner]
US 20170224869A1 · Shah · 2017 [cited by examiner]
US 20190254807A1 · Limem · 2019 [cited by examiner]
US 20190343620A1 · Mlodinow · 2019 [cited by examiner]
US 20200046489A1 · Feinberg · 2020 [cited by examiner]
US 20200113647A1 · Hermann · 2020 [cited by examiner]
US 20200113665A1 · Priewe · 2020 [cited by examiner]
US 20200115490A1 · Dove et al. · 2020 [cited by applicant]
US 20200375715A1 · Egnelöv · 2020 [cited by examiner]
US 20200375726A1 · Limem · 2020 [cited by examiner]
US 20210052367A1 · Yang · 2021 [cited by examiner]
US 20210093444A1 · Feinberg · 2021 [cited by examiner]
US 20210161645A1 · Rocco · 2021 [cited by examiner]
US 20210186678A1 · Chhaya · 2021 [cited by examiner]
US 20210369912A1 · Toro Estrella · 2021 [cited by examiner]
US 20210401459A1 · Gronovich · 2021 [cited by examiner]
US 20220125612A1 · Chen · 2022 [cited by examiner]
US 20220133467A1 · Lazarus · 2022 [cited by examiner]
US 20220133507A1 · Sanchez · 2022 [cited by examiner]
JP 2004130118A · 2004 [cited by applicant]
WO 2020234576A1 · 2020 [cited by applicant]
College Station Technologies Conference, Polymers for Advanced PAT, Book of Abstracts, Aug. 8-10, 2019, 125 pages. [cited by applicant]